You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital
|
|---|---|
| Published in |
Journal of Pharmaceutical Policy and Practice, June 2020
|
| DOI | 10.1186/s40545-020-00238-y |
| Pubmed ID | |
| Authors |
Woh Yon Mak, Jivanraj R. Nagarajah, Hannah Abdul Halim, Anitha Ramadas, Zulsairi Mohd Pauzi, Lay Ting Pee, Nirmala Jagan |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 44 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 11 | 25% |
| Lecturer | 3 | 7% |
| Student > Master | 3 | 7% |
| Researcher | 2 | 5% |
| Student > Ph. D. Student | 2 | 5% |
| Other | 3 | 7% |
| Unknown | 20 | 45% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 20% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 16% |
| Nursing and Health Professions | 5 | 11% |
| Unspecified | 1 | 2% |
| Environmental Science | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 20 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2020.
All research outputs
#15,616,469
of 23,220,133 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#308
of 418 outputs
Outputs of similar age
#249,521
of 399,383 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#24
of 29 outputs
Altmetric has tracked 23,220,133 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 418 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,383 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.